Inventor

BANCHEREAU JACQUES F

US36 patents

⚠️ This page may combine multiple inventors who share the name “BANCHEREAU JACQUES F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BANCHEREAU JACQUES F

BAYLOR RES INST

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)

Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays

Anti-interferon alpha monoclonal antibodies and methods for use

Systemic lupus erythematosus diagnostic assay

Anti-CD40 antibodies

Vaccines directed to langerhans cells

Compositions and methods for the systemic treatment of arthritis

Adjuvants and processes to induce a specific type of immune response

Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responses

Compositions and methods for the systemic treatment of arthritis

BAYLOR RES INSTITUTE

Nucleic acids encoding anti-CD40 antibodies

Anti-CD40 antibodies

Method of making an anti-CD40 antibody

Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides

Fusion proteins comprising an anti-CD40 antibody and cancer antigens

Fusion proteins comprising an anti-CD40 antibody and cancer antigens

Compositions and methods for the systemic treatment of arthritis

Compositions and methods for the systemic treatment of arthritis

Methods and compositions for treating breast cancer with dendritic cell vaccines

BANCHEREAU JACQUES F

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Anti-CD40 antibodies

Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef

Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)

Dendritic cell vaccines

ZURAWSKI GERARD

Anti-CD40 targeted fusion proteins

Fusion protein with HIV antigen

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

Fusion proteins comprising antibody and HPV E6 and E7 antigens

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

SCHERING CORP

Monoclonal antibodies to human CTLA-8 (IL-17A)

Monoclonal antibodies specific for b cells and htlv-i transformed t cells

ZURAWSKI GERALD

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

OH SANGKON

Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)